Page last updated: 2024-11-02

pd 169316 and Retinoblastoma

pd 169316 has been researched along with Retinoblastoma in 1 studies

2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole: p38 MAP kinase inhibitor

Retinoblastoma: A malignant tumor arising from the nuclear layer of the retina that is the most common primary tumor of the eye in children. The tumor tends to occur in early childhood or infancy and may be present at birth. The majority are sporadic, but the condition may be transmitted as an autosomal dominant trait. Histologic features include dense cellularity, small round polygonal cells, and areas of calcification and necrosis. An abnormal pupil reflex (leukokoria); NYSTAGMUS, PATHOLOGIC; STRABISMUS; and visual loss represent common clinical characteristics of this condition. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2104)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Poulaki, V1
Mitsiades, CS1
Joussen, AM1
Lappas, A1
Kirchhof, B1
Mitsiades, N1

Other Studies

1 other study available for pd 169316 and Retinoblastoma

ArticleYear
Constitutive nuclear factor-kappaB activity is crucial for human retinoblastoma cell viability.
    The American journal of pathology, 2002, Volume: 161, Issue:6

    Topics: Antineoplastic Agents; Apoptosis; Calpain; Caspase 3; Caspases; Cell Survival; Dipeptides; DNA; Doxo

2002